Skip to main content
. 2022 Mar 23;315(3):379–386. doi: 10.1007/s00403-022-02348-w

Table 2.

Relation between response and different criteria of the patients

Variables Responders (n = 66) Non responders (n = 34) χ2 p-value
No % No %
Residence

 Urban

 Rural

34

32

51.5

48.5

10

24

29.4

70.6

4.45 0.035*
Type of vitiligo
 Focal 6 9.1 10 29.4 6.89 0.009*
 Unilateral 2 3.0 2 5.9 FET 0.603
 Acrofacial 16 24.2 2 5.9 2.93 0.086
 Vulgaris 24 36.4 18 52.9 2.53 0.112
 Mixed 18 27.3 2 5.9 6.41 0.011*
Genotype

 Taq I

 Homo TT

 Homo tt

 Hetero Tt

36

8

22

54.5

12.1

33.3

14

6

14

41.2

17.6

41.2

1.67 0.433

Apa I

 Homo AA

 Homo aa

 Hetero Aa

36

0

30

54.5

0

45.5

12

4

18

35.3

7.7

52.9

9.75 0.008*
Taq I alleles

 T

 t

94

38

71.2

28.8

42

26

61.8

38.2

1.84 0.175
Apa I alleles

 A

 a

102

30

77.3

22.7

42

26

61.8

38.2

5.35 0.021*
VIDA score (median & range) 1.0 (−1.00–4.00) 2.00 (0.00–4.00) Z = 2.16 0.009*
VASI score before treatment (median & range) 3.00 (0.50–8.75) 2.25 (0.25–3.90) Z = 2.82 0.005*
VASI score after treatment (median & range) 1.75 (0.10–6.75) 2.25 (0.25–3.95) Z = 1.66 0.097
% of change in VASI score (median & range) −45 (−91.30/4.35) 0 (−10/12.86) Z = 7.51  < 0.001*

FET Fisher's exact test; Z Mann–Whitney test; χ2 chi-square test; t Student’s t test

*P is significant if < 0.05